H.R. 5675 — Reported in House

IB Union Calendar No. 577 115th CONGRESS 2d Session H. R. 5675 [Report No. 115–743, Part I] IN THE HOUSE OF REPRESENTATIVES May 3, 2018 Mr. Bilirakis (for himself, Mr. Ben Ray Luján of New Mexico, Mr. Roskam, and Mr. Levin) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned June 12, 2018Additional sponsors: Mrs. Blackburn, Mr. Walden, and Mr. Posey June 12, 2018 Reported from the Committee on Energy and Commerce June 12, 2018The Committee on Ways and Means discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed A BILL To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries. 1. Requiring prescription drug plan sponsors under Medicare to establish drug management programs for at-risk beneficiaries Section 1860D–4(c) of the Social Security Act (42 U.S.C. 1395w–104(c)) is amended— (1) in paragraph (1), by inserting after subparagraph (E) the following new subparagraph: (F) With respect to plan years beginning on or after January 1, 2021, a drug management program for at-risk beneficiaries described in paragraph (5). ; and (2) in paragraph (5)(A), by inserting (and for plan years beginning on or after January 1, 2021, a PDP sponsor shall) after A PDP sponsor may. June 12, 2018 Reported from the Committee on Energy and CommerceJune 12, 2018The Committee on Ways and Means discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed